Half-year report · HY
4021.TEDINET S100X0X9
Period2025-04-01 → 2025-09-30
Filed2025-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥130.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥251.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥118.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥29.6bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥28.3bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥29.8bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥58.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥27.9bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥29.8bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥28.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥22.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥43.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20.5bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥23.2bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥20.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥322.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥330.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥311.4bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥80.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥94.6bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥241.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥236.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥231.6bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥34.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.5bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥34.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥27.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥48.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥59.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥46.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥8.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥17.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥35.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥35.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥31.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥168.45 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥313.26 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.78 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.9% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-04-01 → 2025-09-30 | ¥14.8bn |
| Otherother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥6.8bn |
| Otherother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥8.0bn |
| Otherother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥789m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥61.9bn |
| Reconciling Itemsreconciling | revenue external | 2025-04-01 → 2025-09-30 | −¥12.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥49.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥3.1bn |
| Agricultural Chemical Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥42.3bn |
| Agricultural Chemical Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥36.7bn |
| Agricultural Chemical Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥5.6bn |
| Agricultural Chemical Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥12.0bn |
| Chemical Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥18.8bn |
| Chemical Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥12.5bn |
| Chemical Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥6.4bn |
| Chemical Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥97m |
| Functional Materialsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥54.4bn |
| Functional Materialsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥39.4bn |
| Functional Materialsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥15.0bn |
| Functional Materialsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥17.4bn |
| Healthcarereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.8bn |
| Healthcarereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.8bn |
| Healthcarereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥48m |
| Healthcarereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥695m |
| Wholesalereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥58.8bn |
| Wholesalereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥44.4bn |
| Wholesalereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥14.4bn |
| Wholesalereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥192.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥142.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥49.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥32.7bn |
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥12.0bn |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| Otherother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.5bn |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥34m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥59.1bn |
| Reconciling Itemsreconciling | revenue external | 2024-04-01 → 2024-09-30 | −¥12.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥46.6bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥3.6bn |
| Agricultural Chemical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥39.2bn |
| Agricultural Chemical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥32.1bn |
| Agricultural Chemical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.0bn |
| Agricultural Chemical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.4bn |
| Chemical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥17.9bn |
| Chemical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.8bn |
| Chemical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| Chemical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥292m |
| Functional Materialsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥48.6bn |
| Functional Materialsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥36.0bn |
| Functional Materialsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥12.6bn |
| Functional Materialsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.5bn |
| Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| Healthcarereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥74m |
| Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Wholesalereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥56.3bn |
| Wholesalereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥43.0bn |
| Wholesalereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| Wholesalereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥177.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥130.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥46.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥32.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 576
| Item | Context | Value | Unit |
|---|---|---|---|
| Deferred tax assets | InterimInstant | 592000000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 4782000000 | JPY |
| Net defined benefit asset | InterimInstant | 4778000000 | JPY |
| Other ioa | Prior1YearInstant | 4742000000 | JPY |
| Other ioa | InterimInstant | 4723000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -56000000 | JPY |
| Allowance for doubtful accounts ioa by group | InterimInstant | -55000000 | JPY |
| Investments and other assets | Prior1YearInstant | 34523000000 | JPY |
| Investments and other assets | InterimInstant | 36624000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 120411000000 | JPY |
| Noncurrent assets | InterimInstant | 125299000000 | JPY |
| Assets | Prior1YearInstant | 330763000000 | JPY |
| Assets | InterimInstant | 322238000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 19877000000 | JPY |
| Notes and accounts payable trade | InterimInstant | 20565000000 | JPY |
| Short term loans payable | Prior1YearInstant | 19987000000 | JPY |
| Short term loans payable | InterimInstant | 11073000000 | JPY |
| Commercial papers liabilities | Prior1YearInstant | 8996000000 | JPY |
| Commercial papers liabilities | InterimInstant | 3998000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 514000000 | JPY |
| Current portion of long term loans payable | InterimInstant | 448000000 | JPY |
| Income taxes payable | Prior1YearInstant | 9957000000 | JPY |
| Income taxes payable | InterimInstant | 6592000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 2576000000 | JPY |
| Provision for bonuses | InterimInstant | 2730000000 | JPY |
| Provision for loss on business of subsidiaries and affiliates cl | Prior1YearInstant | 213000000 | JPY |
| Provision for loss on business of subsidiaries and affiliates cl | InterimInstant | 12000000 | JPY |
| Other cl | Prior1YearInstant | 17096000000 | JPY |
| Other cl | InterimInstant | 19214000000 | JPY |
| Current liabilities | Prior1YearInstant | 79218000000 | JPY |
| Current liabilities | InterimInstant | 64635000000 | JPY |
| Bonds payable | Prior1YearInstant | 10000000000 | JPY |
| Bonds payable | InterimInstant | 10000000000 | JPY |
| Long term loans payable | Prior1YearInstant | 977000000 | JPY |
| Long term loans payable | InterimInstant | 579000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 1063000000 | JPY |
| Deferred tax liabilities | InterimInstant | 2155000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | Prior1YearInstant | 264000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | InterimInstant | 258000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 542000000 | JPY |
| Net defined benefit liability | InterimInstant | 601000000 | JPY |
| Other ncl | Prior1YearInstant | 2515000000 | JPY |
| Other ncl | InterimInstant | 2643000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 15363000000 | JPY |
| Noncurrent liabilities | InterimInstant | 16237000000 | JPY |
| Liabilities | Prior1YearInstant | 94582000000 | JPY |
| Liabilities | InterimInstant | 80872000000 | JPY |
| Capital stock | Prior1YearInstant | 18942000000 | JPY |
| Capital stock | InterimInstant | 18942000000 | JPY |
| Capital surplus | Prior1YearInstant | 13613000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |